Anzeige
Mehr »
Login
Sonntag, 11.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Kurseskalation am Montag? Diese Gamechanger-News macht es möglich!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N7N8 ISIN: KYG4818G1010 Ticker-Symbol: 6IB 
Stuttgart
09.04.21
06:15 Uhr
7,950 Euro
-0,500
-5,92 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
INNOVENT BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
INNOVENT BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
8,1008,40017:34
7,9508,60009.04.

Aktuelle News zur INNOVENT BIOLOGICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.03.INNOVENT BIO: Parsaclisib (IBI376) Granted Breakthrough Therapy Designation by NMPA4
31.03.INNOVENT BIO (01801): GRANT OF SHARE OPTIONS AND NON-EXEMPT CONNECTED TRANSACTION - PROPOSED GRANT OF RESTRICTED SHARES TO DIRECTORS AND GRANT OF RESTRICTED SHARES1
INNOVENT BIOLOGICS Aktie jetzt für 0€ handeln
30.03.UBS Hikes INNOVENT BIO (01801.HK) TP to $134.4; Rated Buy4
30.03.INNOVENT BIO (01801.HK) Annual Loss Narrows to RMB998M; Nil Div3
29.03.INNOVENT BIO (01801): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 20202
23.03.Eli Lilly, China's Innovent launch lung cancer drug18
11.02.CCBIS starts Innovent Biologics (01801) at HK$1156
03.02.Innovent and Lilly win second China OK for Tyvyt in frontline NSCLC, ramping up pressure on king Keytruda5
03.02.Eli Lilly, Innovent Biologics' Sintilimab Injection Receives China Approval For A Type Of Lung Cancer10
03.02.Lilly, Innovent Bio's Tyvyt + chemotherapy OK'd in China for lung cancer8
03.02.INNOVENT BIO (01801): INSIDE INFORMATION - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES TYVYT (SINTILIMAB INJECTION) AS FIRST-LINE THERAPY FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER1
25.01.INNOVENT BIO (01801): NEXT DAY DISCLOSURE RETURN2
19.01.Etana to launch Innovent Biologics' cancer drug BYVASDA in Indonesia3
19.01.Innovent out-licenses Byvasda rights to Etana for launch in Indonesia1
15.01.Innovent Bio (01801) to place shares for HK$4,726.8m8
15.01.INNOVENT BIO (01801): PLACING OF NEW SHARES UNDER GENERAL MANDATE-
13.01.Lilly and Innovent Bio's application for Tyvyt combo as first-line therapy for liver cancer OK'd in China6
13.01.INNOVENT BIO (01801): VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE SUPPLEMENTAL NEW DRUG APPLICATION FOR TYVYT (SINTILIMAB INJECTION) IN COMBINATION WITH BYVASDA ...1
12.01.Lilly and Innovent Bio's application for Tyvyt as second-line therapy for lung cancer OK'd in China4
12.01.INNOVENT BIO (01801): VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE SUPPLEMENTAL NEW DRUG APPLICATION FOR TYVYT (SINTILIMAB INJECTION) AS SECOND-LINE THERAPY IN SQUAMOUS ...-
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1